Infectious Diseases and the Law
Hospital Acquired Conditions Conference
The Graduate Summer Session in Epidemiology
Practical Antimicrobial Stewardship: Implementation and Expansion in Healthcare Facilities
Find Practice Guidelines
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
Senators Urged to Support Antibiotic R&D Bill
A bill to establish a new FDA approval pathway for antibacterial drugs to treat life-threatening infections where there exists an unmet medical need has been introduced in the Senate. IDSA members asked to engage their Senators.
IDSA Spearheads Advocacy Effort for AR Funding
IDSA was joined by 56 groups in a letter to congressional appropriators calling for funding to address antimicrobial resistance.
Better Tests, Better Care: The Promise of Next Generation Diagnostics
This report for policymakers highlights the need for new diagnostics and recommends policies to stimulate diagnostics R&D and clinical integration.
IDSA, PIDS, and HIVMA Comments on NIH Physician-Scientist Workforce Report
IDSA, along with PIDS and HIVMA, jointly commented on the NIH Physician-Scientist Workforce Working Group report highlighting recommendations to improve the state of the physician-scientist workforce.
IDSA President Provides Testimony on the Need for New Antibiotics
On September 19th,
IDSA President Barbara Murray provided testimony to the Health Subcommittee of
the House Energy & Commerce Committee on the need for a coordinated federal
strategy to spur research and development for new antibiotics.
Tell Congress #CutsHurt!
Your help is needed to send a strong message to Congress that federal agency and program funding levels need to be finalized in the weeks ahead, so that new cuts are not set into motion.
Take Three Minutes to Support Antibiotic Development
Urge Congress to help speed patient access to the most urgently needed new antibacterial drugs.
IDSA Members Call on Congress to Advance LPAD Pathway
IDSA members answered a request from the House Energy and Commerce Committee on proposals to spur drug research and development.
1 of 8
FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa
Outbreak of Recent HIV and HCV Infections among Persons Who Inject Drugs
Clinical Advisory: Ocular Syphilis in the United States
Experiences of CDC and Emory Healthcare in Managing Persons Under Investigation for Ebola
>> Read More
From the President What Matters Most to YouWhite House AR PlanIDSA Journal Club
Shortages of key antibiotics, including gold-standard therapies and drugs for resistant infections, are on the rise, a new study in CID finds.
The Infectious Diseases Society of America (IDSA) welcomes the release of the National Action Plan for Combating Antibiotic Resistant Bacteria (CARB).
A new study in CID suggests that nasal drops of harmless bacteria can inhibit the related bug that sometimes causes meningococcal disease.
From the President How to Avoid a Payment Penalty IDWeek 2015 IDSA Journal Club
Changes in the Physician Quality Reporting System (PQRS) have important implications. If you don’t report on relevant measures during this calendar year, you will see a payment penalty in 2017. See Manage Your Practice for IDSA’s guidance on relevant measures for ID specialists.
1 of 7
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2015 Infectious Diseases Society of America